Cargando…

Hormonal therapies and venous thrombosis: Considerations for prevention and management

BACKGROUND: Venous thromboses are well‐established complications of hormonal therapy. Thrombosis risk is seen with both hormonal contraceptive agents and with hormone replacement therapy for menopause and gender transition. Over the past several decades, large epidemiological studies have helped bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	LaVasseur, Corinne, Neukam, Suvi, Kartika, Thomas, Samuelson Bannow, Bethany, Shatzel, Joseph, DeLoughery, Thomas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399360/ https://www.ncbi.nlm.nih.gov/pubmed/36032216 http://dx.doi.org/10.1002/rth2.12763

Ejemplares similares

Re: Hormonal therapies and venous thrombosis: The estrogen matters! Morimont et al.
por: LaVasseur, Corinne, et al.
Publicado: (2023)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
por: Olson, Sven R., et al.
Publicado: (2019)

Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias
por: Baldwin, Maureen K., et al.
Publicado: (2023)

Sex Matters: Policy on Reporting Sex as a Biological Variable at Research and Practice in Thrombosis and Hemostasis
por: Samuelson Bannow, Bethany, et al.
Publicado: (2023)

Hormonal therapies and venous thrombosis: considerations for prevention and management—a reappraisal
por: Douxfils, Jonathan, et al.
Publicado: (2023)

Are outpatient anticoagulation management services the wave of the future (again)?
por: Samuelson Bannow, Bethany
Publicado: (2022)

Platelet reactivity and platelet count in women with iron deficiency treated with intravenous iron
por: Elstrott, Benjamin K., et al.
Publicado: (2022)

Clinical data for intravenous iron – debunking the hype around hypersensitivity
por: Achebe, Maureen, et al.
Publicado: (2020)

How I approach bleeding in hospitalized patients
por: Bannow, Bethany Samuelson, et al.
Publicado: (2023)

Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions
por: Arastu, Asad H., et al.
Publicado: (2022)

Hemostatic complications associated with ventricular assist devices
por: Hilal, Talal, et al.
Publicado: (2019)

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
por: Auerbach, Michael, et al.
Publicado: (2021)

Management of anticoagulation for cancer‐associated thrombosis in patients with thrombocytopenia: A systematic review
por: Samuelson Bannow, Bethany R., et al.
Publicado: (2018)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
por: Samuelson Bannow, Bethany, et al.
Publicado: (2021)

Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations
por: Moyer, Genevieve Claire, et al.
Publicado: (2018)

The contact activation system as a potential therapeutic target in patients with COVID‐19
por: Shatzel, Joseph J., et al.
Publicado: (2020)

Menstrual Technology Innovations and the Implications for Heavy Menstrual Bleeding
por: Liberty, Abigail, et al.
Publicado: (2023)

Monitoring Cr Intermediates and Reactive Oxygen Species with Fluorescent Probes during Chromate Reduction
por: DeLoughery, Zachary, et al.
Publicado: (2014)

Hormonal therapies and venous thrombosis: Estrogen matters!
por: Morimont, Laure, et al.
Publicado: (2023)

Transcriptional Regulation and Mechanism of SigN (ZpdN), a pBS32-Encoded Sigma Factor in Bacillus subtilis
por: Burton, Aisha T., et al.
Publicado: (2019)

Loss of Forkhead box M1 promotes erythropoiesis through increased proliferation of erythroid progenitors
por: Youn, Minyoung, et al.
Publicado: (2017)

Prevention of venous thrombosis and pulmonary embolism /
por: Sharnoff, J. G.
Publicado: (1980)

Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives?
por: Fruzzetti, Franca, et al.
Publicado: (2018)

NELL2-Robo3 complex structure reveals mechanisms of receptor activation for axon guidance
por: Pak, Joseph S., et al.
Publicado: (2020)

Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative
por: Cushman, Mary, et al.
Publicado: (2018)

ATM and KAT5 safeguard replicating chromatin against formaldehyde damage
por: Ortega-Atienza, Sara, et al.
Publicado: (2016)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
por: Zakai, Neil A., et al.
Publicado: (2021)

Venous Thrombosis
Publicado: (1901)

Venous Thrombosis
por: Mitchell, J. R. A.
Publicado: (1988)

P‐ and E‐ selectin in venous thrombosis and non‐venous pathologies
por: Purdy, Megan, et al.
Publicado: (2022)

Venous Thrombosis Secondary to Acute Cytomegalovirus Infection in an Immunocompetent Host: Consideration for New Screening Guidelines
por: Ngu, Sam, et al.
Publicado: (2018)

EFFECTIVENESS OF DEEP VENOUS THROMBOSIS PREVENTION IN TOTAL HIP ARTHROPLASTY
por: MANFREDI, VICTOR MARTINS, et al.
Publicado: (2021)

EFFICIENCY OF DEEP VENOUS THROMBOSIS PREVENTION IN PROXIMAL FEMUR FRACTURES
por: GARCIA, JOÃO VITOR DA CRUZ, et al.
Publicado: (2022)

Investigation and analysis of status of mechanical prevention of venous thrombosis in ICU
por: Xiaoxiao, Guan, et al.
Publicado: (2022)

Administration of Monoclonal Antibody for COVID-19 in Patient Homes
por: Malani, Anurag N., et al.
Publicado: (2021)

A serine sensor for multicellularity in a bacterium
por: Subramaniam, Arvind R, et al.
Publicado: (2013)

The Treatment of Venous Thrombosis
Publicado: (1909)

Causes of venous thrombosis
por: Rosendaal, F. R.
Publicado: (2016)

Periprostatic venous thrombosis
por: Paulino, Eduardo, et al.
Publicado: (2016)

Venous thrombosis in neonates
por: Bhatt, Mihir D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5946kqjr68a64ob56slmu5h9im